1. Home
  2. STKL vs OCS Comparison

STKL vs OCS Comparison

Compare STKL & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • OCS
  • Stock Information
  • Founded
  • STKL 1973
  • OCS 2003
  • Country
  • STKL United States
  • OCS Switzerland
  • Employees
  • STKL N/A
  • OCS N/A
  • Industry
  • STKL Precious Metals
  • OCS Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKL Basic Materials
  • OCS Health Care
  • Exchange
  • STKL Nasdaq
  • OCS Nasdaq
  • Market Cap
  • STKL 865.2M
  • OCS 916.3M
  • IPO Year
  • STKL N/A
  • OCS N/A
  • Fundamental
  • Price
  • STKL $6.98
  • OCS $21.41
  • Analyst Decision
  • STKL Strong Buy
  • OCS Strong Buy
  • Analyst Count
  • STKL 4
  • OCS 5
  • Target Price
  • STKL $9.50
  • OCS $28.80
  • AVG Volume (30 Days)
  • STKL 395.7K
  • OCS 64.5K
  • Earning Date
  • STKL 02-26-2025
  • OCS 03-17-2025
  • Dividend Yield
  • STKL N/A
  • OCS N/A
  • EPS Growth
  • STKL N/A
  • OCS N/A
  • EPS
  • STKL N/A
  • OCS N/A
  • Revenue
  • STKL $711,683,000.00
  • OCS $1,027,571.00
  • Revenue This Year
  • STKL $15.65
  • OCS $7.98
  • Revenue Next Year
  • STKL $9.32
  • OCS $853.39
  • P/E Ratio
  • STKL N/A
  • OCS N/A
  • Revenue Growth
  • STKL 16.96
  • OCS N/A
  • 52 Week Low
  • STKL $4.88
  • OCS $10.55
  • 52 Week High
  • STKL $8.11
  • OCS $23.08
  • Technical
  • Relative Strength Index (RSI)
  • STKL 35.34
  • OCS 52.07
  • Support Level
  • STKL $7.23
  • OCS $20.95
  • Resistance Level
  • STKL $7.68
  • OCS $21.86
  • Average True Range (ATR)
  • STKL 0.22
  • OCS 0.56
  • MACD
  • STKL -0.04
  • OCS -0.26
  • Stochastic Oscillator
  • STKL 4.11
  • OCS 56.18

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: